Prostate-specific antigen responses were similar between transdermal estradiol and hormone therapy combined with androgen receptor inhibitors in prostate cancer.

Although CAR T-cell therapies have been found effective against certain difficult-to-treat malignancies, they are not devoid of safety concerns.

High prostate-specific antigen levels before High-Intensity Focused Ultrasound were linked to higher recurrence and treatment failure in intermediate-risk prostate cancer.

The influenza A virus genome consists of eight segments of single-stranded, negative-sense viral RNA, which encode multiple ...

A nurse-led mobile healthcare clinic identified a high proportion of clinically significant prostate cancers among men from ...

Among those with intermediate-risk prostate cancer, high PSA levels prior to HIFU led to an increased risk of overall ...

Discover Microbix Biosystems' strong Q1 2025 earnings, 40% revenue growth, and operational gains. Learn about innovative launches & fiscal growth strategies.

Antigen presentation is critical to initiate the adaptive immune response to cancer, instigating the immune response by processing tumor antigens and presenting them to T cells of the adaptive immune ...

Peptic ulcer disease is a common digestive disorder in which acid and digestive enzymes cause the lining of the stomach or the first part of the small intestine (duodenum) to erode. A peptic ulcer ...

Sequences, structures, and annotations can be easily downloaded from the AACDB website, speeding up the development of structure-based algorithms and analysis pipelines to characterize ...

CD19-directed chimeric antigen receptor (CAR) T-cell therapy, originally developed for haematological malignancies, has recently emerged as a promising therapy for patients with autoimmune diseases.